Masterclasses in Psoriatic Disease—November 1 to 2, 2024; Dallas, Texas

Dhiman Basu, MD: Bimekizumab for Psoriatic Arthritis, Non-radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis

Dr. Basu, a Texas-based rheumatologist, reviews data on a newly approved agent for PSA, nr‐axSpa, and AS.

MORE COVERAGE FROM MASTERCLASSES IN DERMATOLOGY 2024

In this recap of the connective tissue disease session at Masterclasses APP+, Dr. Merola provides insight on how dermatologists can serve as the front-line provider for treating systemic lupus through the screening, diagnosis, and treatment of cutaneous lupus.

...